Prevalence of hereditary antithrombin mutations is higher than estimated in patients with thrombotic events.
2013
Antithrombin is the major inhibitor of blood coagulation, primarily inactivating thrombin and factor Xa. Inherited antithrombin deficiency is associated with an increased risk of thromboembolism. Its prevalence is estimated to be about 0.2% in the general healthy population, whereas it is 2% in pati
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
19
Citations
NaN
KQI